The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
Open accessAbstract
The hippocampal dentate gyrus in the adult mammalian brain contains neural stem/progenitor cells (NS/PCs) capable of generating new neurons, i.e., neurogenesis. Most drugs of abuse examined to date decrease adult hippocampal neurogenesis, but the effects of cannabis (marijuana or cannabinoids) on hippocampal neurogenesis remain unknown. This study aimed at investigating the potential regulatory capacity of the potent synthetic cannabinoid HU210 on hippocampal neurogenesis and its possible correlation with behavioral change. We show that both embryonic and adult rat hippocampal NS/PCs are immunoreactive for CB1 cannabinoid receptors, indicating that cannabinoids could act on CB1 receptors to regulate neurogenesis. This hypothesis is supported by further findings that HU210 promotes proliferation, but not differentiation, of cultured embryonic hippocampal NS/PCs likely via a sequential activation of CB1 receptors, G(i/o) proteins, and ERK signaling. Chronic, but not acute, HU210 treatment promoted neurogenesis in the hippocampal dentate gyrus of adult rats and exerted anxiolytic- and antidepressant-like effects. X-irradiation of the hippocampus blocked both the neurogenic and behavioral effects of chronic HU210 treatment, suggesting that chronic HU210 treatment produces anxiolytic- and antidepressant-like effects likely via promotion of hippocampal neurogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Functional neurogenesis in the adult hippocampus
van Praag, H., Schinder, A. F., Christie, B. R., Toni, N., Palmer, T. D., & Gage, F. H. (2002) · Nature · doi:10.1038/4151030a · Cited by 2,853
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“This is unlikely, however, as we observed no significant difference in the number of rats climbing (41, 42) among HU210-, AM281-, and vehicle-treated groups in the first 5 minutes of the pretest sessions of the FST.”
BackgroundMethodMilestones of neuronal development in the adult hippocampus
Kempermann, G., Jessberger, S., Steiner, B., & Kronenberg, G. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.05.013 · Cited by 1,460
Reynolds, B. A., & Weiss, S. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0090 · Cited by 1,368
Gritti, A., Parati, E. A., Cova, L., Frolichsthal, P., Galli, R., Wanke, E., Faravelli, L., Morassutti, D. J., Roisen, F. J., Nickel, D. D., et al. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01091.1996 · Cited by 1,029
Kempermann, G., Gast, D., Kronenberg, G., Yamaguchi, M., & Gage, F. H. (2002) · Development · doi:10.1242/dev.00203 · Cited by 1,003
Cited by
Sorted by citations
Items 101–200 of 526
Hill, M. N., Ho, W. ‐. V., Sinopoli, K. J., Viau, V., Hillard, C. J., & Gorzalka, B. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301092 · Cited by 118
Wiring and firing neuronal networks: endocannabinoids take center stage
Harkany, T., Mackie, K., & Doherty, P. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.007 · Cited by 125
Inhibition of human hair follicle growth by endo‐and exocannabinoids
Telek, A., Bı́ró, T., Bodó, E., Tóth, B. I., Borbíró, I., Kunos, G., & Paus, R. (2007) · The FASEB Journal · doi:10.1096/fj.06-7689com · Cited by 113
Hill, M. N., & Patel, S. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-19 · Cited by 120
Neurobiology of cannabinoid receptor signaling
Lutz, B. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/blutz · Cited by 119
Physical activity and the endocannabinoid system: an overview
Tantimonaco, M., Ceci, R., Sabatini, S., Catani, M. V., Rossi, A., Gasperi, V., & Maccarrone, M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1575-6 · Cited by 112
Mechanisms of antidepressant resistance
El-Hage, W., Leman, S., Camus, V., & Belzung, C. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00146 · Cited by 111
Anhedonia in depression symptomatology: appetite dysregulation and defective brain reward processing
Coccurello, R. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112041 · Cited by 106
Kondo, M., Nakamura, Y., Ishida, Y., & Shimada, S. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.153 · Cited by 112
Galve‐Roperh, I., Palazuelos, J., Aguado, T., & Guzmán, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0028-y · Cited by 113
Open questions in current models of antidepressant action
Tanti, A., & Belzung, C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00585.x · Cited by 115
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
David, D. J. P., Wang, J., Samuels, B. A., Rainer, Q., Mendez‐David, I., Gardier, A. M., & Hen, R. (2010) · The Neuroscientist · doi:10.1177/1073858409360281 · Cited by 115
Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders
Chambers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.005 · Cited by 110
Synthetic Cannabinoids: A Pharmacological and Toxicological Overview
Bravo, R. R., Silva, R. S., Malheiro, R. F., Carmo, H., Carvalho, F. D., da Silva, D. D., & Silva, J. P. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031122-113758 · Cited by 106
Vitalis, T., Lainé, J., Simon, A., Roland, A. B., Leterrier, C., & Lenkei, Z. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06484.x · Cited by 108
REGULATORS OF ADULT NEUROGENESIS IN THE HEALTHY AND DISEASED BRAIN
Grote, H., & Hannan, A. J. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04610.x · Cited by 105
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development
Kim, H., Spector, A. A., & Xiong, Z. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.07.002 · Cited by 104
The Toxicology of Cannabis and Cannabis Prohibition
Grotenhermen, F. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790151 · Cited by 101
Dubreucq, S., Koehl, M., Abrous, D. N., Marsicano, G., & Chaouloff, F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.01.017 · Cited by 103
Dentate gyrus neurogenesis and depression
Sahay, A., Drew, M. R., & Hen, R. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63038-6 · Cited by 104
N‐docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation
Rashid, M. A., Katakura, M., Kharebava, G., Kevala, K., & Kim, H. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12255 · Cited by 101
Hill, M. N., Kambo, J. S., Sun, J. C., Gorzalka, B. B., & Galea, L. A. M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05061.x · Cited by 101
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Gaffuri, A.-L., Ladarré, D., & Lenkei, Z. (2012) · Pharmacology · doi:10.1159/000339075 · Cited by 107
Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
Abate, G., Uberti, D. L., & Tambaro, S. (2021) · Biology · doi:10.3390/biology10060542 · Cited by 103
Oudin, M. J., Gajendra, S., Williams, G., Hobbs, C., Lalli, G., & Doherty, P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5483-10.2011 · Cited by 101
Neurogenesis and antidepressant action
Park, S. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03043-5 · Cited by 101
Vinod, K. Y., Xie, S., Psychoyos, D., Hungund, B. L., Cooper, T. B., & Tejani‐Butt, S. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036743 · Cited by 97
Prolonged glucocorticoid treatment decreases cannabinoid CB 1 receptor density in the hippocampus
Hill, M. N., Carrier, E. J., Ho, W. ‐. V., Shi, L., Patel, S., Gorzalka, B. B., & Hillard, C. J. (2007) · Hippocampus · doi:10.1002/hipo.20386 · Cited by 96
Jiang, B., Wang, Y., Wang, H., Song, L., Huang, C., Zhu, Q., Wu, F., & Zhang, W. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13668 · Cited by 97
Endocannabinoids via CB 1 receptors act as neurogenic niche cues during cortical development
Díaz-Alonso, J., Guzmán, M., & Galve‐Roperh, I. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0385 · Cited by 94
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Fuzi polysaccharide-1 produces antidepressant-like effects in mice
Yan, H., Qu, H.-D., Sun, L., Li, S.-J., Cao, X., Fang, Y., Jie, W., Bean, J. C., Wu, W.-K., Zhu, X., et al. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990733 · Cited by 91
Compagnucci, C., Siena, S. D., Bustamante, M. B., Giacomo, D. D., Tommaso, M. D., Maccarrone, M., Grimaldi, P., & Sette, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054271 · Cited by 95
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Fride, E., Gobshtis, N., Dahan, H., Weller, A., Giuffrida, A., & Ben‐Shabat, S. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(09)81006-6 · Cited by 92
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
Bambico, F. R., Duranti, A., Tontini, A., Tarzia, G., & Gobbi, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168029 · Cited by 94
The endocannabinoid system as a target for the treatment of cannabis dependence
Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.018 · Cited by 94
Zhang, Z., Wang, W., Zhong, P., Liu, S. J., Long, J. Z., Zhao, L., Gao, H., Cravatt, B. F., & Liu, Q. (2015) · Hippocampus · doi:10.1002/hipo.22344 · Cited by 89
Dyall, S. C. (2017) · Lipids · doi:10.1007/s11745-017-4292-8 · Cited by 95
Ren, S., Wang, Z., Zhang, Y., & Chen, N. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0385-7 · Cited by 88
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
Neuropeptides in depression: Role of VGF
Thakker‐Varia, S., & Alder, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 88
Neurogenesis in neurological and psychiatric diseases and brain injury: From bench to bedside
Ruan, L., Lau, B. W.-M., Wang, J., Huang, L., Zhuge, Q., Wang, B. Z., Jin, K., & So, K. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.12.006 · Cited by 89
The Public Health Effects of Legalizing Marijuana
Anderson, D. M., & Rees, D. I. (2023) · Journal of Economic Literature · doi:10.1257/jel.20211635 · Cited by 87
Endocannabinoids, cannabinoids and the regulation of anxiety
Petrie, G. N., Nastase, A. S., Aukema, R. J., & Hill, M. N. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108626 · Cited by 91
Adult neurogenesis and the memories of drug addiction
Canales, J. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0730-6 · Cited by 88
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
Roche, M., & Finn, D. P. (2010) · Pharmaceuticals · doi:10.3390/ph3082517 · Cited by 88
Khan, A. A., Shekh‐Ahmad, T., Khalil, A., Walker, M. C., & Ali, A. B. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14202 · Cited by 86
Cannabinoids and emotionality: a neuroanatomical perspective
McLaughlin, R. J., & Gobbi, G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.052 · Cited by 84
Oudin, M. J., Hobbs, C., & Doherty, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07831.x · Cited by 81
Proapoptotic effect of endocannabinoids in prostate cancer cells
Orellana‐Serradell, O., Poblete, C., Sánchez, C., Castellón, E. A., Iván Gallegos, M., Huidobro, C., Llanos, M. N., & Contreras, H. R. (2015) · Oncology Reports · doi:10.3892/or.2015.3746 · Cited by 81
The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80
Trazzi, S., Steger, M., Mitrugno, V. M., Bartesaghi, R., & Ciani, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043711 · Cited by 80
Silva, M. H. (2020) · Birth Defects Research · doi:10.1002/bdr2.1661 · Cited by 81
Xapelli, S., Agasse, F., Sardà‐Arroyo, L., Bernardino, L. I., Santos, T., Ribeiro, F. F., Valero, J., Bragança, J., Schitine, C., Reis, R. A. D. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063529 · Cited by 77
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Hillard, C. J., & Liu, Q.-S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660735 · Cited by 82
McLaughlin, R. J., Hill, M. N., Morrish, A. C., & Gorzalka, B. B. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee7b44 · Cited by 77
Bai, G., Cheung, I., Shulha, H. P., Coelho, J. E., Li, P., Dong, X., Jakovcevski, M., Wang, Y., Grigorenko, A., Jiang, Y., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu561 · Cited by 77
Chiou, S., Ku, H., Tsai, T., Lin, H., Chen, L., Chien, C., Ho, L. L. ‐., Lee, C., & Chang, Y. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706766 · Cited by 73
G-Protein-Coupled Receptors in Adult Neurogenesis
Doze, V. A., & Perez, D. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004762 · Cited by 75
Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors
Hayase, T. (2011) · BMC Pharmacology · doi:10.1186/1471-2210-11-6 · Cited by 71
Tanti, A., & Belzung, C. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1612-z · Cited by 75
Enhancement of endocannabinoid signaling and the pharmacotherapy of depression
Mangieri, R. A., & Piomelli, D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.003 · Cited by 73
Vigli, D., Cosentino, L., Raggi, C., Laviola, G., Woolley-Roberts, M., & Filippis, B. D. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.029 · Cited by 75
BDNF regulates neuronal sensitivity to endocannabinoids
Maison, P., Walker, D. J., Walsh, F. S., Williams, G. H., & Doherty, P. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.011 · Cited by 69
Rodríguez‐Gaztelumendi, A., Rojo, M. L., Pazos, Á., & Díaz, Á. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05898.x · Cited by 68
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Boorman, E., Zajkowska, Z., Ahmed, R., Pariante, C. M., & Zunszain, P. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4105-9 · Cited by 68
Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents
Heath, T. S., Burroughs, Z. T., Thompson, A. J., & Tecklenburg, F. (2012) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-17.2.177 · Cited by 66
Role for Neuronal Nitric-Oxide Synthase in Cannabinoid-Induced Neurogenesis
Kim, S. H., Won, S. J., Mao, X. O., Ledent, C. A., Jin, K., & Greenberg, D. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107698 · Cited by 66
The COX‐2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain
Goncalves, M. B. C. V., Williams, E., Yip, P. K., Yáñez‐Muñoz, R. J., Williams, G. H., & Doherty, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00618.x · Cited by 65
Kruk-Słomka, M., Michalak, A., & Biała, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.051 · Cited by 64
Pan, B., Zhong, P., Sun, D., & Liu, Q.-S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1040-11.2011 · Cited by 64
Functions of the CB1 and CB2 Receptors in Neuroprotection at the Level of the Blood–Brain Barrier
Vendel, E., & de Lange, E. C. M. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8314-x · Cited by 67
Cannabinoid Modulation of the Stressed Hippocampus
Scarante, F. F., Vila-Verde, C., Lopes, V. D., Ferreira‐Junior, N. C., Guimarães, F. S., & Campos, A. C. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00411 · Cited by 66
Borsotto, M., Veyssière, J., Maati, H. M. O., Devader, C., Mazella, J., & Heurteaux, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12953 · Cited by 65
Marco, E. M., Adriani, W., Canese, R., Podo, F., Viveros, M., & Laviola, G. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.006 · Cited by 62
Folate stimulates ERK1/2 phosphorylation and cell proliferation in fetal neural stem cells
Zhang, X., Huang, G., Tian, Z., Da-lin, R., & Wilson, J. X. (2009) · Nutritional Neuroscience · doi:10.1179/147683009x423418 · Cited by 62
Neural tube defects and impaired neural progenitor cell proliferation in Gβ1 ‐deficient mice
Okae, H., & Iwakura, Y. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22256 · Cited by 62
Troutt, W. D., & DiDonato, M. D. (2015) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2015.1074766 · Cited by 61
Pathways from Cannabis to Psychosis: A Review of the Evidence
Burns, J. K. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00128 · Cited by 61
Wang, Y., Cui, X., Liu, Y., Gao, F., Wei, D., Li, X., Wang, H., Tan, Q., & Jiang, W. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.07.004 · Cited by 62
Self-citationSmaga, I., Bystrowska, B., Gawliński, D., Pomierny, B., Stankowicz, P., & Filip, M. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9465-0 · Cited by 62
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
Moreira, F. A., de Aguiar, D. C., Campos, A. C., Lisboa, S. F. D. S., Terzian, A. L. B., Resstel, L. B. M., & Guimarães, F. S. (2008) · Neural Plasticity · doi:10.1155/2009/625469 · Cited by 62
The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
Sorkhou, M., Bedder, R. H., & George, T. P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.630247 · Cited by 61
Johnson, D., Letchumanan, V., Thum, C. C., Thurairajasingam, S., & Lee, L. (2023) · Nutrients · doi:10.3390/nu15061382 · Cited by 72
Different effects of mild and severe seizures on hippocampal neurogenesis in adult rats
Yang, F., Wang, J., Han, J., Zhao, G., & Jiang, W. (2008) · Hippocampus · doi:10.1002/hipo.20409 · Cited by 60
Self-citationMahar, I., Tan, S., Davoli, M. A., Domínguez-López, S., Qiang, C., Rachalski, A., Turecki, G., & Mechawar, N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026610 · Cited by 62
Vlachou, S., & Panagis, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990433 · Cited by 62
Wang, Y., Gu, N., Duan, T., Kesner, P., Blaskovits, F., Liu, J., Lu, Y., Li, T., Gao, F., Harris, C. S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.22 · Cited by 60
Harrison, E. L., & Baune, B. T. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.31 · Cited by 60
Häring, M., Grieb, M., Monory, K., Lutz, B., & Moreira, F. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.09.002 · Cited by 63
Graham, E. S., Ball, N., Scotter, E. L., Narayan, P. J., Dragunow, M., & Glass, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602516200 · Cited by 59
Suliman, N. A., Taib, C. N. M., Moklas, M. A. M., & Basir, R. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9806-x · Cited by 59
Bambico, F. R., & Belzung, C. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_234 · Cited by 61
Balu, D. T., Hodes, G. E., Anderson, B. T., & Lucki, I. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.234 · Cited by 59
Campos, A. C., Ferreira, F. R., Silva, W. A., & Guimarães, F. S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.11.016 · Cited by 57
Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats
Wang, Y., Yang, F., Liu, Y.-F., Gao, F., & Jiang, W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.035 · Cited by 56
Self-citationLi, T. X., Nie, H., Zhang, Y., Chen, Y., Peng, Z., Cai, M., Wei, H., Qin, P., Dong, H., & Xiong, L. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.027 · Cited by 58
Endocannabinoid system in the adult rat circumventricular areas: An immunohistochemical study
Suárez, J., Romero‐Zerbo, S., Rivera, P., Bermúdez‐Silva, F. J., Pérez, J., de Fonseca, F. R., & Fernández‐Llebrez, P. (2010) · The Journal of Comparative Neurology · doi:10.1002/cne.22382 · Cited by 57
Metadata
- Authors
- Jiang, W.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-11-01
- Volume
- 115
- Issue
- 11
- Pages
- 3104-3116
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1253627
- OpenAlex
- W2097448914
- Cited by
- 527
- References
- 62
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 18 · 2023: 17 · 2022: 16 · 2021: 30 · 2020: 24 · 2019: 23 · 2018: 19 · 2017: 18 · 2016: 19 · 2015: 27 · 2014: 39 · 2013: 33 · 2012: 33
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Journal of Clinical Investigation (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Saskatchewan Health Research Foundation
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoids, HU-210, CB1 receptor, adult hippocampal neurogenesis, dentate gyrus, neural stem/progenitor cells, anxiolytic effects, antidepressant-like effects, ERK signaling, G protein signaling
- MeSH terms
- Animals, Antidepressive Agents, Arachidonic Acids, Cannabinoids, Cells, Cultured, Hippocampus, Male, Neurons, Rats, Inbred F344, Stem Cells, Dronabinol, Anti-Anxiety Agents, Signal Transduction, Rats, Wistar, Rats, Long-Evans, Receptor, Cannabinoid, CB1, Cell Proliferation, Rats, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review